WuXi PharmaTech Completes $3.3B Ally Bridge, Hillhouse-Backed Go-Private Deal

Login to View

New York Stock Exchange-listed pharmaceutical research and development services provider WuXi PharmaTech (Cayman) Inc. has completed a US$3.3 billion go-private deal, in which it has been acquired by a group of private equity investors and company management, according to an announcement.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS